NCT04395079 2026-02-09Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological MalignanciesJonsson Comprehensive Cancer CenterPhase 2 Active not recruiting9 enrolled